Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for the treatment of cannabis dependence: working mechanisms
2015-005154-35Phase 3Active
- Sponsor
- UZ Brussel
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in cannabis use disorder (CUD), sponsored by UZ Brussel. Started Jan 2016; status: active.
02
Drugs
acetylcysteine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on 2015-005154-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005154-35.